Rocuronium for Rapid Sequence Induction in Elective Caesarean Section

Background: Rocuronium with its rapid onset of action is one of the most commonly used safe and effective muscle relaxants for intubation and maintenance of muscle relaxation during surgical procedures. Objective: To demonstrate the safety and efficiency of rocuronium for rapid sequence induction in caesarean section. Methods: This prospective observational study was conducted on 75 pregnant women (17–48 years of age) undergone elective caesarean section between November 2014 and June 2015, after preoxygenation, rapid sequence induction started with rocuronium 0.6 mg/kg where 25% of the dose given just before thiopentone and the rest of the dose thereafter. Patients were intubated, mechanically ventilated and anesthesia maintained with isoflurane and air in oxygen. The vital signs of the patient monitored. The newborn babies were received by a pediatrician and evaluated at 1 and 5 min APGAR scores. The condition of the tracheal intubation evaluated by the intubator. Results: Rocuronium used for rapid sequence intubation provided satisfactory intubating conditions, with intraoperative hemodynamic stabilization and no aspiration related complications. The mothers and the new born babies had shown no serious side effects. Conclusion: Rocuronium is safe and effective for rapid sequence intubation and maintenance of muscle relaxation during elective caesarean section.